BAMS
INSY

Bellevue Asset Management (Switzerland)’s Insys Therapeutics, Inc. INSY Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$6.64M Buy
232,000
+22,000
+10% +$610K 1.01% 32
2015
Q3 		$5.98M Buy
210,000
+90,000
+75% +$3.31M 0.97% 37
2015
Q2 		$4.31M Buy
+120,000
New +$3.74M 0.6% 57

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s INSY Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Insys Therapeutics, Inc. (INSY) stake by 10% in Q4 2015, buying an estimated $610K and bringing the position to 232,000 shares worth $6.64M. The position accounts for 1.01% of the portfolio, ranked #32.

Bellevue Asset Management (Switzerland) first reported a position in INSY in Q2 2015 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold INSY as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 232,000 shares of Insys Therapeutics, Inc. worth $6.64M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 22,000 Insys Therapeutics, Inc. shares in Q4 2015, an estimated $610K.
  • Insys Therapeutics, Inc. made up 1.01% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #32 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Insys Therapeutics, Inc. in Q2 2015 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.